Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Oncogene

• Publication date

  2009-02-12

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/onc.2008.436PMID 19060927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of Histone Modifications by Mass Spectrometry

  2008cited by this paper
• HDACs and HDAC inhibitors in colon cancer

  2008cited by this paper
• Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator

  2007cited by this paper
• Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.

  2007cited by this paper
• Function of the SIRT1 protein deacetylase in cancer.

  2007cited by this paper
• Top-down proteomics on a chromatographic time scale using linear ion trap fourier transform hybrid mass spectrometers.

  2007cited by this paper
• Cross‐Talk between Aging and Cancer

  2007cited by this paper
• Histone deacetylase inhibitors: molecular mechanisms of action

  2007cited by this paper
• Histone deacetylases and cancer

  2007cited by this paper
• Epigenetics and aging: the targets and the marks.

  2007cited by this paper
• Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

  2007cited by this paper
• Discovery and development of SAHA as an anticancer agent

  2007cited by this paper
• SirT1 fails to affect p53‐mediated biological functions

  2006cited by this paper
• 2D Structure Depiction

  2006influential reference
• Sirtuins in aging and age-related disease.

  2006cited by this paper
• The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma.

  2006cited by this paper
• Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation

  2006influential reference
• Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells

  2006influential reference
• Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

  2006cited by this paper
• SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis.

  2006influential reference
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

  2006cited by this paper
• Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.

  2006influential reference
• Comparative and pharmacophore model for deacetylase SIRT1

  2006cited by this paper
• Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.

  2005cited by this paper
• Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.

  2005cited by this paper
• Calorie restriction--the SIR2 connection.

  2005cited by this paper
• Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.

  2005influential reference
• Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

  2005influential reference
• The Flavoring Agent Dihydrocoumarin Reverses Epigenetic Silencing and Inhibits Sirtuin Deacetylases

  2005cited by this paper
• Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.

  2005influential reference
• Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

  2005cited by this paper
• Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.

  2004cited by this paper
• Trastuzumab Plus Tamoxifen: Anti-Proliferative and Molecular Interactions in Breast Carcinoma

  2004cited by this paper
• Exploring protein native states and large‐scale conformational changes with a modified generalized born model

  2004cited by this paper
• The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

  2003influential reference
• Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

  2003cited by this paper
• Force fields for protein simulations.

  2003cited by this paper
• Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1*

  2002cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• Structure of the histone deacetylase SIRT2

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• Identification of a small molecule inhibitor of Sir2p

  2001cited by this paper
• Crystal structure of a SIR2 homolog-NAD complex.

  2001cited by this paper
• Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening*

  2001cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• p53 mutations in colorectal cancer.

  1990cited by this paper

• Benzodeazaoxaflavin Sirtuin Inhibitors Inhibit Schistosoma mansoni Sirt2 and Cause Phenotypic Changes and Lethality in Schistosomula and Adult Worm Stages

  2025cites this paper
• Sirtuin modulators: a review of patents from 2020 to 2024

  2025cites this paper
• Role of SIRT1-mediated mitochondrial and Akt pathways in glioblastoma cell death induced by Cotinus coggygria flavonoid nanoliposomes [Retraction]

  2025cites this paper
• Targeting sirtuins for cancer therapy: epigenetics modifications and beyond

  2024cites this paper
• Molecular Signaling and Clinical Implications in the Human Aging-cancer Cycle.

  2024cites this paper
• Opportunities and Difficulties in the Repurposing of HDAC Inhibitors as Antiparasitic Agents

  2024cites this paper
• Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective

  2024cites this paper
• SIRT1: a novel regulator in colorectal cancer.

  2024cites this paper
• Fragment Screening Reveals Novel Scaffolds against Sirtuin-2-Related Protein 1 from Trypanosoma brucei

  2024cites this paper
• Sirtuin insights: bridging the gap between cellular processes and therapeutic applications

  2024cites this paper
• The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy

  2024cites this paper
• Activation and inhibition of sirtuins: From bench to bedside

  2024cites this paper
• Current Trends in Sirtuin Activator and Inhibitor Development

  2024cites this paper
• A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research.

  2023cites this paper
• Targeting SIRT1-regulated autophagic cell death as a novel therapeutic avenue for cancer prevention.

  2023cites this paper
• Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy.

  2023cites this paper
• Sirtuin 1 as a potential biomarker of undernutrition in the elderly: a narrative review

  2023cites this paper
• The roles of sirtuins in ferroptosis

  2023cites this paper
• Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy.

  2023cites this paper
• Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases

  2022cites this paper
• Sirtuin modulators: past, present, and future perspectives.

  2022cites this paper
• Versatile role of sirtuins in metabolic disorders: From modulation of mitochondrial function to therapeutic interventions

  2022cites this paper
• The beneficial role of SIRT1 in preventive or therapeutic options of Neurodegenerative Diseases.

  2022cites this paper
• The sirtuin family in health and disease

  2022cites this paper
• Virtual Screening in the Identification of Sirtuins’ Activity Modulators

  2022cites this paper
• Vorinostat (SAHA) and Breast Cancer: An Overview

  2021cites this paper
• Sirtuins, healthspan, and longevity in mammals

  2021cites this paper
• Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency

  2021cites this paper
• Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators

  2021cites this paper
• Effect of Hydroalcoholic Extract of Ephedra major, Momordica charantia, and Resveratrol on Cytotoxicity and Caspase-3 Genes Expression Level in MCF-7 Breast Cancer Cell Line

  2021cites this paper
• Medicinal chemistry of histone deacetylase inhibitors

  2021cites this paper
• Chronic Exercise Mitigates the Effects of Sirtuin Inhibition by Salermide on Endothelium-Dependent Vasodilation

  2021cites this paper
• Promising drug discovery strategies for sirtuin modulators: what lessons have we learnt?

  2021cites this paper
• Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry.

  2021cites this paper
• The bifunctional roles of sirtuins and their therapeutic potential in cancer

  2021cites this paper
• SIRT2 and FOXO3a expressions in the cerebral cortex and hippocampus of young and aged male rats: antioxidant and anti-apoptotic effects of melatonin

  2021cites this paper
• Sirtuin Modulators in Cellular and Animal Models of Human Diseases

  2021cites this paper
• Sirtuins and the hallmarks of cancer

  2021cites this paper
• Sirtuins as endogenous regulators of lung fibrosis: A current perspective.

  2020cites this paper
• Lysine acetylation as drug target in fungi: an underexplored potential in Aspergillus spp.

  2020cites this paper
• Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1H-Purine-2,6-Diones as Potent Inhibitors of SIRT1, SIRT2, SIRT3, and SIRT5

  2020cites this paper
• Computer-Aided Drug Design for the Identification of Novel Antischistosomal Compounds.

  2020cites this paper
• Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine

  2020cites this paper
• Emerging Role of Sirtuins in Breast Cancer Metastasis and Multidrug resistance: Implication for Novel Therapeutic Strategies Targeting Sirtuins.

  2020cites this paper
• A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy

  2020cites this paper
• Schistosoma mansoni: Methods and Protocols

  2020cites this paper
• Synthesis of new phenolic compounds and biological evaluation as antiproliferative agents

  2020cites this paper
• A novel drug-combination screen in zebrafish identifies epigenetic small molecule candidates for Duchenne muscular dystrophy

  2020cites this paper
• Epigenetic Control Using Small Molecules in Cancer

  2020cites this paper
• QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives

  2020cites this paper
• Sirtuin modulators: where are we now? A review of patents from 2015 to 2019

  2020cites this paper
• Targeting histone acetylation/deacetylation in parasites: an update (2017-2020).

  2020cites this paper
• The Versatility of Sirtuin-1 in Endocrinology and Immunology

  2020cites this paper
• Role of Metabolism in Regulating Immune Cell Fate Decisions

  2020cites this paper
• A new SIRT1 inhibitor, MHY2245, induces autophagy and inhibits energy metabolism via PKM2/mTOR pathway in human ovarian cancer cells

  2020cites this paper
• Advances of Proteomics in Novel PTM Discovery: Applications in Cancer Therapy

  2019cites this paper
• Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer

  2019cites this paper
• Rikkunshito attenuates induction of epithelial-mesenchymal switch via activation of Sirtuin1 in ovarian cancer cells.

  2019cites this paper
• Unraveling the Unbinding Pathways of Products Formed in Catalytic Reactions Involved in SIRT1-3: A Random Acceleration Molecular Dynamics Simulation Study

  2019cites this paper
• Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma Mansoni (SmSirt2).

  2019cites this paper
• Sirtuin Inhibitors and Activators

  2019cites this paper
• NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer

  2019cites this paper
• Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype

  2019cites this paper
• Epigenetic Drug Discovery for Cancer

  2019cites this paper
• The sirtuin family in cancer

  2019cites this paper
• Chromone-3-aldehyde derivatives – sirtuin 2 inhibitors for correction of muscular dysfunction

  2019cites this paper
• Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

  2019cites this paper
• Epigenetic Tools in Chronic Pain Studies

  2019cites this paper
• Inhibition of SIRT1/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells

  2019cites this paper
• Identification of novel quinazoline derivatives as potent antiplasmodial agents.

  2019cites this paper
• Chemical Tools with Fluorescence Switches for Verifying Epigenetic Modifications.

  2019cites this paper
• An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.

  2019cites this paper
• Sirtuins as Drug Targets

  2019cites this paper
• New chemical tools for probing activity and inhibition of the NAD+-dependent lysine deacylase sirtuin 2

  2018cites this paper
• Comparative Proteomic Analysis of Lysine Acetylation in Trypanosomes.

  2018cites this paper
• The Current State of NAD+‐Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets

  2018cites this paper
• Recent advances in inhibitors of sirtuin1/2: an update and perspective.

  2018cites this paper
• Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.

  2018cites this paper
• Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer.

  2018cites this paper
• Peptide‐Based Fluorescent Probes for Deacetylase and Decrotonylase Activity: Toward a General Platform for Real‐Time Detection of Lysine Deacylation

  2018cites this paper
• Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.

  2018cites this paper
• ROLES OF SIRT 1 IN CANCER / AGEING

  2018cites this paper
• Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.

  2018cites this paper
• Molecular Dynamics Simulation of SIRT1 Inhibitor from Indonesian Herbal Database

  2018cites this paper
• Sirtuin 1 and oral cancer.

  2018cites this paper
• Deregulation of the imprinted DLK1-DIO3 locus ncRNAs is associated with replicative senescence of human adipose-derived stem cells

  2018cites this paper
• Sirtuin Modulators and Brain Aging

  2018cites this paper
• Involvement of spinal SIRT1 in development of chronic constriction injury induced neuropathic pain in rats.

  2018cites this paper
• A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation

  2018cites this paper
• SIRT2‐mediated inactivation of p73 is required for glioblastoma tumorigenicity

  2018cites this paper
• Silent Information Regulator 2 from Trypanosoma cruzi Is a Potential Target to Infection Control

  2018cites this paper
• Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).

  2017cites this paper
• Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.

  2017cites this paper
• Use of the Monte Carlo Method for OECD Principles‐Guided QSAR Modeling of SIRT1 Inhibitors

  2017cites this paper
• Management of Alzheimer's disease-An insight of the enzymatic and other novel potential targets.

  2017cites this paper
• Synthesis and Biological Evaluation of Imines Structurally Related to Resveratrol as Dual Inhibitors of VEGF Protein Secretion and hTERT Gene Expression1

  2017cites this paper
• Transcriptional regulation by the oncoprotein STAT5: role of acetylation and deacetylation processes

  2017cites this paper
• Sirtuins at the crossroads of stemness, aging, and cancer

  2017cites this paper
• 1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors

  2016cites this paper
• HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells

  2016influential citation